# Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract

> **NCT00622362** · PHASE2 · TERMINATED · sponsor: **Laboratorios Leti, S.L.** · enrollment: 3 (actual)

## Conditions studied

- Allergic Asthma

## Interventions

- **BIOLOGICAL:** DEPIGOID Dermatophagoides pteronyssinus
- **BIOLOGICAL:** Polymerized TOL of Dermatophagoides pteronyssinus
- **BIOLOGICAL:** Placebo Comparator

## Key facts

- **NCT ID:** NCT00622362
- **Lead sponsor:** Laboratorios Leti, S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622362, "Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00622362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*